Genome Editing: Past, Present, and Future
- PMID: 29259529
- PMCID: PMC5733845
Genome Editing: Past, Present, and Future
Abstract
The CRISPR-Cas genome editing tools have been adopted rapidly in the research community, and they are quickly finding applications in the commercial sector as well. Lest we lose track of the broader context, this Perspective presents a brief review of the history of the genome editing platforms and considers a few current technological issues. It then takes a very limited view into the future of this technology and highlights some of the societal issues that require examination and discussion.
Keywords: CRISPR-Cas; DNA repair; Genome editing; TALENs; zinc-finger nucleases.
Similar articles
-
Therapeutic editing of hepatocyte genome in vivo.J Hepatol. 2017 Oct;67(4):818-828. doi: 10.1016/j.jhep.2017.05.012. Epub 2017 May 17. J Hepatol. 2017. PMID: 28527665 Review.
-
The multiplexed CRISPR targeting platforms.Drug Discov Today Technol. 2018 Aug;28:53-61. doi: 10.1016/j.ddtec.2018.01.001. Epub 2018 Feb 4. Drug Discov Today Technol. 2018. PMID: 30205881 Free PMC article. Review.
-
CRISPR/Cas9: an advanced tool for editing plant genomes.Transgenic Res. 2016 Oct;25(5):561-73. doi: 10.1007/s11248-016-9953-5. Epub 2016 Mar 24. Transgenic Res. 2016. PMID: 27012546 Review.
-
Gene Editing With TALEN and CRISPR/Cas in Rice.Prog Mol Biol Transl Sci. 2017;149:81-98. doi: 10.1016/bs.pmbts.2017.04.006. Epub 2017 May 24. Prog Mol Biol Transl Sci. 2017. PMID: 28712502 Review.
-
Genome editing: the road of CRISPR/Cas9 from bench to clinic.Exp Mol Med. 2016 Oct 14;48(10):e265. doi: 10.1038/emm.2016.111. Exp Mol Med. 2016. PMID: 27741224 Free PMC article. Review.
Cited by
-
Climate solution or corporate co-optation? US and Canadian publics' views on agricultural gene editing.PLoS One. 2022 Mar 21;17(3):e0265635. doi: 10.1371/journal.pone.0265635. eCollection 2022. PLoS One. 2022. PMID: 35313327 Free PMC article.
-
Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A±).Stem Cell Rev Rep. 2023 Nov;19(8):2774-2789. doi: 10.1007/s12015-023-10602-5. Epub 2023 Aug 31. Stem Cell Rev Rep. 2023. PMID: 37653182 Free PMC article.
-
Recent Advances in CRISPR/Cas9-Based Genome Editing Tools for Cardiac Diseases.Int J Mol Sci. 2021 Oct 12;22(20):10985. doi: 10.3390/ijms222010985. Int J Mol Sci. 2021. PMID: 34681646 Free PMC article. Review.
-
Linking autism risk genes to morphological and pharmaceutical screening by high-content imaging: Future directions and opinion.Psychiatry Clin Neurosci. 2025 Aug;79(8):435-446. doi: 10.1111/pcn.13847. Epub 2025 Jun 10. Psychiatry Clin Neurosci. 2025. PMID: 40492449 Free PMC article. Review.
-
Genome Editing and Diabetic Cardiomyopathy.Adv Exp Med Biol. 2023;1396:103-114. doi: 10.1007/978-981-19-5642-3_7. Adv Exp Med Biol. 2023. PMID: 36454462 Free PMC article.
References
-
- Muller HJ. Artificial transmutation of the gene. Science. 1927;66:84–7. - PubMed
-
- Auerbach C, Robson JM, Carr JG. Chemical production of mutations. Science. 1947;105:243–7. - PubMed
-
- Rothstein RJ. One-step gene disruption in yeast. Methods Enzymol. 1983;101:202–11. - PubMed
-
- Smithies O, Gregg RG, Boggs SS, Koralewski MA, Kucherlapati RS. Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature. 1985;317(6034):230–4. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous